|
Summary:
Giga School Student Tablet Set Country:
Japan
Notice Type:
Tender Notice Deadline:
03 Apr 2025 Posting Date:
19 Mar 2025 |
|
Summary:
A: Butolisilane Sodium Injection (25Mg, 0.5Ml/Tube) 3: B: Elapegudemase (Genetic Recombinant) Intramuscular Formulation (2.4Mg, 1.5Ml/Voluminous) 23: C: Durvalumab (Genetic Recombinant) Formulation (500Mg, 10Ml/Voluminous) 10. Country:
Japan
Notice Type:
Tender Notice Deadline:
01 Apr 2025 Posting Date:
17 Mar 2025 |
|
Summary:
8Th Pharmaceutical Product Country:
Japan
Notice Type:
Tender Notice Deadline:
29 Mar 2025 Posting Date:
14 Mar 2025 |
|
Summary:
A Set Of Provisions For Resident Registration Codes For Code Generation In Accordance With Article 30-9-2 Of The Basic Resident Register Act Country:
Japan
Notice Type:
Tender Notice Deadline:
26 Mar 2025 Posting Date:
11 Mar 2025 |
Japan pharmaceutical products Tenders Contracts and Bids
Find Japan pharmaceutical products tenders and government contracts. Search business opportunities for Japan pharmaceutical products tenders, Japan serums tenders, Japan vaccine tenders, Japan clinical products tenders..
Healthcare and Medicine